Empirically establishing drug exposure records directly from untargeted metabolomics data
bioRxiv [Preprint]. 2024 Oct 26:2024.10.07.617109. doi: 10.1101/2024.10.07.617109.
Published on October 17, 2024
ABSTRACT
Despite extensive efforts, extracting information on medication exposure from clinical records remains challenging. To complement this approach, we developed the tandem mass spectrometry (MS/MS) based GNPS Drug Library. This resource integrates MS/MS data for drugs and their metabolites/analogs with controlled vocabularies on exposure sources, pharmacologic classes, therapeutic indications, and mechanisms of action. It enables direct analysis of drug exposure and metabolism from untargeted metabolomics data independent of clinical records. Our library facilitates stratification of individuals in clinical studies based on the empirically detected medications, exemplified by drug-dependent microbiota-derived N-acyl lipid changes in a cohort with human immunodeficiency virus. The GNPS Drug Library holds potential for broader applications in drug discovery and precision medicine.
PMID:39416075 | PMC:PMC11482764 | DOI:10.1101/2024.10.07.617109
Latest Publications
- HSF2 drives breast cancer progression by acting as a stage-specific switch between proliferation and invasion
- Breast Milk Proteome: Changes in the Different Stages of Lactation and Impacts of Gestational Diabetes Mellitus and Body Mass Index
- Metabolome informs about the chemical exposome and links to brain health
- Designing Fluorescent Estrogen Mimetic 7-hydroxycoumarin Probe Substrates for Human Sulfotransferase Enzymes
- Cholesterol Ester Storage Disease in Two Field Spaniels With Lysosomal Acid Lipase Deficiency